These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2340793)

  • 21. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
    Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
    Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of glycated albumin in end-stage renal failure: evidence for the principle of "physiological microalbuminuria".
    Donnelly SM
    Am J Kidney Dis; 1996 Jul; 28(1):62-6. PubMed ID: 8712223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular handling of circulating glycated albumin in the normal mouse kidney.
    Londoño I; Ghitescu L; Bendayan M
    Am J Physiol; 1995 May; 268(5 Pt 2):F913-21. PubMed ID: 7771519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation.
    Cohen MP; Hud E; Wu VY; Shearman CW
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5089-93. PubMed ID: 18599566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria.
    Kunika K; Yamaoka T; Itakura M
    Diabetes Res Clin Pract; 1997 Apr; 36(1):1-9. PubMed ID: 9187409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic assay of serum glycated albumin.
    Shima K; Ito N; Abe F; Hirota M; Yano M; Yamamoto Y; Uchida T; Noguchi K
    Diabetologia; 1988 Aug; 31(8):627-31. PubMed ID: 3220198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria in NIDDM is caused by increased excretion of unmodified albumin.
    Ishibashi F
    Diabetes; 1996 Jun; 45(6):731-5. PubMed ID: 8635645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis.
    Szkudlarek A; Sułkowska A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():645-53. PubMed ID: 25735846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats.
    Tucker BJ; Rasch R; Blantz RC
    J Clin Invest; 1993 Aug; 92(2):686-94. PubMed ID: 8349807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.
    Ziyadeh FN; Cohen MP
    Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
    Ido Y; Kilo C; Williamson JR
    Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating glycated albumin and glomerular anionic charges.
    Londoño I; Gingras D; Bendayan M
    Exp Diabesity Res; 2003; 4(2):83-92. PubMed ID: 14630570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.
    Eaton JW; Qian M
    Mol Cell Biochem; 2002; 234-235(1-2):135-42. PubMed ID: 12162426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The response of glycated albumin to blood glucose change in the circulation in streptozotocin-diabetic rats--comparison of theoretical values with experimental data.
    Shi K; Tahara Y; Noma Y; Yasukawa K; Shima K
    Diabetes Res Clin Pract; 1992 Sep; 17(3):153-60. PubMed ID: 1425154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of decline in renal function in the diabetic db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus.
    Bent-Hansen L; Feldt-Rasmussen B; Kverneland A; Deckert T
    Diabetologia; 1987 Jan; 30(1):2-4. PubMed ID: 3569694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.
    Cooper ME; Allen TJ; O'Brien RC; Macmillan PA; Clarke B; Jerums G; Doyle AE
    J Hypertens; 1988 Dec; 6(12):1009-16. PubMed ID: 3221096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.